We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Secondary Prevention Treatment in Patients Who Have Suffered a Cardiovascular Event

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01395550
First Posted: July 15, 2011
Last Update Posted: August 30, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
AstraZeneca
June 14, 2011
July 15, 2011
August 30, 2011
January 2010
July 2010   (Final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT01395550 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Secondary Prevention Treatment in Patients Who Have Suffered a Cardiovascular Event
Secondary Prevention Treatment in Patients Who Have Suffered a Cardiovascular Event.
AstraZeneca was interested in knowing how Cardiologists and Physicians treat patients who have suffered a cardiovascular event.
Not Provided
Observational
Time Perspective: Retrospective
Not Provided
Not Provided
Probability Sample
Patients with cardiovascular events
Cardiovascular Events
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
88
July 2010
July 2010   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • All patients who has experienced cardiovascular events

Exclusion Criteria:

  • Patients with no cardiovascular events.
Sexes Eligible for Study: All
Child, Adult, Senior
No
Contact information is only displayed when the study is recruiting subjects
Not Provided
 
 
NCT01395550
NIS-CZA-XXX-2011/1
No
Not Provided
Not Provided
AstraZeneca
AstraZeneca
Not Provided
Not Provided
AstraZeneca
August 2011